News
12. Januar 2026
Many thanks to Vialto Partners Germany – working together for KCNQ2 research
We would like to express our heartfelt thanks to Vialto Partners Germany and all employees who took part in the Christmas fundraising campaign. Thanks to this wonderful initiative, a total of €3,000 was raised!
12. Januar 2026
Important news from European KCNQ2 research
The European research initiative EDERA has announced the results of its first major funding program for preclinical therapy projects in rare diseases
16. Dezember 2025
REMEDi4ALL highlights JNJ-37822681 – a promising therapeutic opportunity for rare epilepsies like KCNQ2-DEE
In this article, REMEDi4ALL reports on the work of the international research consortium TREATKCNQ, which is investigating an existing experimental compound — JNJ-37822681 — as a potential therapy for KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE).
Events
Vergangene Veranstaltung: 01. September
Everesting 2018
The event of the year! An athlete on a mountain bike conquers the "Trierer Kuhweg" 62 times. We are talking about an extreme distance in endurance sports.
Read more